img

Global DNA Repair Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global DNA Repair Drugs Market Research Report 2024

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
According to Mr Accuracy reports’s new survey, global DNA Repair Drugs market is projected to reach US$ 1993.3 million in 2034, increasing from US$ 593.6 million in 2024, with the CAGR of 18.4% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Repair Drugs market research.
Key manufacturers engaged in the DNA Repair Drugs industry include 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group and GlaxoSmithKline, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of DNA Repair Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole DNA Repair Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global DNA Repair Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Segment by Type
PARP Inhibitors
Other

Segment by Application


Oncological
Stroke

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The DNA Repair Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 DNA Repair Drugs Market Overview
1.1 Product Overview and Scope of DNA Repair Drugs
1.2 DNA Repair Drugs Segment by Type
1.2.1 Global DNA Repair Drugs Market Value Comparison by Type (2024-2034)
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 DNA Repair Drugs Segment by Application
1.3.1 Global DNA Repair Drugs Market Value by Application: (2024-2034)
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global DNA Repair Drugs Revenue 2018-2034
1.4.2 Global DNA Repair Drugs Sales 2018-2034
1.4.3 Global DNA Repair Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 DNA Repair Drugs Market Competition by Manufacturers
2.1 Global DNA Repair Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global DNA Repair Drugs Average Price by Manufacturers (2018-2023)
2.4 Global DNA Repair Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Repair Drugs, Product Type & Application
2.7 DNA Repair Drugs Market Competitive Situation and Trends
2.7.1 DNA Repair Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DNA Repair Drugs Players Market Share by Revenue
2.7.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DNA Repair Drugs Retrospective Market Scenario by Region
3.1 Global DNA Repair Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global DNA Repair Drugs Global DNA Repair Drugs Sales by Region: 2018-2034
3.2.1 Global DNA Repair Drugs Sales by Region: 2018-2023
3.2.2 Global DNA Repair Drugs Sales by Region: 2024-2034
3.3 Global DNA Repair Drugs Global DNA Repair Drugs Revenue by Region: 2018-2034
3.3.1 Global DNA Repair Drugs Revenue by Region: 2018-2023
3.3.2 Global DNA Repair Drugs Revenue by Region: 2024-2034
3.4 North America DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America DNA Repair Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America DNA Repair Drugs Sales by Country (2018-2034)
3.4.3 North America DNA Repair Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe DNA Repair Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe DNA Repair Drugs Sales by Country (2018-2034)
3.5.3 Europe DNA Repair Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Repair Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific DNA Repair Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific DNA Repair Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific DNA Repair Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America DNA Repair Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America DNA Repair Drugs Sales by Country (2018-2034)
3.7.3 Latin America DNA Repair Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Repair Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa DNA Repair Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa DNA Repair Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DNA Repair Drugs Sales by Type (2018-2034)
4.1.1 Global DNA Repair Drugs Sales by Type (2018-2023)
4.1.2 Global DNA Repair Drugs Sales by Type (2024-2034)
4.1.3 Global DNA Repair Drugs Sales Market Share by Type (2018-2034)
4.2 Global DNA Repair Drugs Revenue by Type (2018-2034)
4.2.1 Global DNA Repair Drugs Revenue by Type (2018-2023)
4.2.2 Global DNA Repair Drugs Revenue by Type (2024-2034)
4.2.3 Global DNA Repair Drugs Revenue Market Share by Type (2018-2034)
4.3 Global DNA Repair Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global DNA Repair Drugs Sales by Application (2018-2034)
5.1.1 Global DNA Repair Drugs Sales by Application (2018-2023)
5.1.2 Global DNA Repair Drugs Sales by Application (2024-2034)
5.1.3 Global DNA Repair Drugs Sales Market Share by Application (2018-2034)
5.2 Global DNA Repair Drugs Revenue by Application (2018-2034)
5.2.1 Global DNA Repair Drugs Revenue by Application (2018-2023)
5.2.2 Global DNA Repair Drugs Revenue by Application (2024-2034)
5.2.3 Global DNA Repair Drugs Revenue Market Share by Application (2018-2034)
5.3 Global DNA Repair Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 4SC AG
6.1.1 4SC AG Corporation Information
6.1.2 4SC AG Description and Business Overview
6.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 4SC AG DNA Repair Drugs Product Portfolio
6.1.5 4SC AG Recent Developments/Updates
6.2 ARCAGY/ GINECO GROUP
6.2.1 ARCAGY/ GINECO GROUP Corporation Information
6.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
6.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
6.2.5 ARCAGY/ GINECO GROUP Recent Developments/Updates
6.3 Bristol Myers Squibb
6.3.1 Bristol Myers Squibb Corporation Information
6.3.2 Bristol Myers Squibb Description and Business Overview
6.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
6.3.5 Bristol Myers Squibb Recent Developments/Updates
6.4 British Columbia Cancer Agency
6.4.1 British Columbia Cancer Agency Corporation Information
6.4.2 British Columbia Cancer Agency Description and Business Overview
6.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
6.4.5 British Columbia Cancer Agency Recent Developments/Updates
6.5 Cambridge University Hospitals NHS Foundation Trust
6.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
6.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
6.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
6.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Corporation Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genentech DNA Repair Drugs Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 Georgetown University
6.6.1 Georgetown University Corporation Information
6.6.2 Georgetown University Description and Business Overview
6.6.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Georgetown University DNA Repair Drugs Product Portfolio
6.7.5 Georgetown University Recent Developments/Updates
6.8 German Breast Group
6.8.1 German Breast Group Corporation Information
6.8.2 German Breast Group Description and Business Overview
6.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 German Breast Group DNA Repair Drugs Product Portfolio
6.8.5 German Breast Group Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson DNA Repair Drugs Description and Business Overview
6.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Jonsson Comprehensive Cancer Center
6.12.1 Jonsson Comprehensive Cancer Center Corporation Information
6.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Description and Business Overview
6.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
6.12.5 Jonsson Comprehensive Cancer Center Recent Developments/Updates
6.13 Karyopharm Therapeutics
6.13.1 Karyopharm Therapeutics Corporation Information
6.13.2 Karyopharm Therapeutics DNA Repair Drugs Description and Business Overview
6.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
6.13.5 Karyopharm Therapeutics Recent Developments/Updates
6.14 KuDOS Pharmaceuticals
6.14.1 KuDOS Pharmaceuticals Corporation Information
6.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Description and Business Overview
6.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
6.14.5 KuDOS Pharmaceuticals Recent Developments/Updates
6.15 National Health Service
6.15.1 National Health Service Corporation Information
6.15.2 National Health Service DNA Repair Drugs Description and Business Overview
6.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 National Health Service DNA Repair Drugs Product Portfolio
6.15.5 National Health Service Recent Developments/Updates
6.16 National Institutes of Health
6.16.1 National Institutes of Health Corporation Information
6.16.2 National Institutes of Health DNA Repair Drugs Description and Business Overview
6.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 National Institutes of Health DNA Repair Drugs Product Portfolio
6.16.5 National Institutes of Health Recent Developments/Updates
6.17 Tesaro
6.17.1 Tesaro Corporation Information
6.17.2 Tesaro DNA Repair Drugs Description and Business Overview
6.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Tesaro DNA Repair Drugs Product Portfolio
6.17.5 Tesaro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Repair Drugs Industry Chain Analysis
7.2 DNA Repair Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Repair Drugs Production Mode & Process
7.4 DNA Repair Drugs Sales and Marketing
7.4.1 DNA Repair Drugs Sales Channels
7.4.2 DNA Repair Drugs Distributors
7.5 DNA Repair Drugs Customers
8 DNA Repair Drugs Market Dynamics
8.1 DNA Repair Drugs Industry Trends
8.2 DNA Repair Drugs Market Drivers
8.3 DNA Repair Drugs Market Challenges
8.4 DNA Repair Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global DNA Repair Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global DNA Repair Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global DNA Repair Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global DNA Repair Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global DNA Repair Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global DNA Repair Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global DNA Repair Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market DNA Repair Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of DNA Repair Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of DNA Repair Drugs, Product Type & Application
Table 12. Global Key Manufacturers of DNA Repair Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DNA Repair Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global DNA Repair Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global DNA Repair Drugs Sales Market Share by Region (2018-2023)
Table 19. Global DNA Repair Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global DNA Repair Drugs Sales Market Share by Region (2024-2034)
Table 21. Global DNA Repair Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global DNA Repair Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global DNA Repair Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global DNA Repair Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America DNA Repair Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America DNA Repair Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America DNA Repair Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America DNA Repair Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America DNA Repair Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe DNA Repair Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe DNA Repair Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe DNA Repair Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe DNA Repair Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe DNA Repair Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific DNA Repair Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific DNA Repair Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific DNA Repair Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific DNA Repair Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific DNA Repair Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America DNA Repair Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America DNA Repair Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America DNA Repair Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America DNA Repair Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America DNA Repair Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa DNA Repair Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa DNA Repair Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa DNA Repair Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa DNA Repair Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa DNA Repair Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global DNA Repair Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global DNA Repair Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global DNA Repair Drugs Sales Market Share by Type (2018-2023)
Table 53. Global DNA Repair Drugs Sales Market Share by Type (2024-2034)
Table 54. Global DNA Repair Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global DNA Repair Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global DNA Repair Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global DNA Repair Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global DNA Repair Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global DNA Repair Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global DNA Repair Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global DNA Repair Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global DNA Repair Drugs Sales Market Share by Application (2018-2023)
Table 63. Global DNA Repair Drugs Sales Market Share by Application (2024-2034)
Table 64. Global DNA Repair Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global DNA Repair Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global DNA Repair Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global DNA Repair Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global DNA Repair Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global DNA Repair Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. 4SC AG Corporation Information
Table 71. 4SC AG Description and Business Overview
Table 72. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. 4SC AG DNA Repair Drugs Product
Table 74. 4SC AG Recent Developments/Updates
Table 75. ARCAGY/ GINECO GROUP Corporation Information
Table 76. ARCAGY/ GINECO GROUP Description and Business Overview
Table 77. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. ARCAGY/ GINECO GROUP DNA Repair Drugs Product
Table 79. ARCAGY/ GINECO GROUP Recent Developments/Updates
Table 80. Bristol Myers Squibb Corporation Information
Table 81. Bristol Myers Squibb Description and Business Overview
Table 82. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Bristol Myers Squibb DNA Repair Drugs Product
Table 84. Bristol Myers Squibb Recent Developments/Updates
Table 85. British Columbia Cancer Agency Corporation Information
Table 86. British Columbia Cancer Agency Description and Business Overview
Table 87. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. British Columbia Cancer Agency DNA Repair Drugs Product
Table 89. British Columbia Cancer Agency Recent Developments/Updates
Table 90. Cambridge University Hospitals NHS Foundation Trust Corporation Information
Table 91. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
Table 92. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product
Table 94. Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
Table 95. Genentech Corporation Information
Table 96. Genentech Description and Business Overview
Table 97. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Genentech DNA Repair Drugs Product
Table 99. Genentech Recent Developments/Updates
Table 100. Georgetown University Corporation Information
Table 101. Georgetown University Description and Business Overview
Table 102. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Georgetown University DNA Repair Drugs Product
Table 104. Georgetown University Recent Developments/Updates
Table 105. German Breast Group Corporation Information
Table 106. German Breast Group Description and Business Overview
Table 107. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. German Breast Group DNA Repair Drugs Product
Table 109. German Breast Group Recent Developments/Updates
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. GlaxoSmithKline DNA Repair Drugs Product
Table 114. GlaxoSmithKline Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Corporation Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Jiangsu Hengrui Medicine DNA Repair Drugs Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Johnson & Johnson DNA Repair Drugs Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Jonsson Comprehensive Cancer Center Corporation Information
Table 126. Jonsson Comprehensive Cancer Center Description and Business Overview
Table 127. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product
Table 129. Jonsson Comprehensive Cancer Center Recent Developments/Updates
Table 130. Karyopharm Therapeutics Corporation Information
Table 131. Karyopharm Therapeutics Description and Business Overview
Table 132. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Karyopharm Therapeutics DNA Repair Drugs Product
Table 134. Karyopharm Therapeutics Recent Developments/Updates
Table 135. KuDOS Pharmaceuticals Corporation Information
Table 136. KuDOS Pharmaceuticals Description and Business Overview
Table 137. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. KuDOS Pharmaceuticals DNA Repair Drugs Product
Table 139. KuDOS Pharmaceuticals Recent Developments/Updates
Table 140. National Health Service Corporation Information
Table 141. National Health Service Description and Business Overview
Table 142. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. National Health Service DNA Repair Drugs Product
Table 144. National Health Service Recent Developments/Updates
Table 145. National Institutes of Health Corporation Information
Table 146. National Institutes of Health Description and Business Overview
Table 147. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. National Institutes of Health DNA Repair Drugs Product
Table 149. National Institutes of Health Recent Developments/Updates
Table 150. Tesaro Corporation Information
Table 151. Tesaro Description and Business Overview
Table 152. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Tesaro DNA Repair Drugs Product
Table 154. Tesaro Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. DNA Repair Drugs Distributors List
Table 158. DNA Repair Drugs Customers List
Table 159. DNA Repair Drugs Market Trends
Table 160. DNA Repair Drugs Market Drivers
Table 161. DNA Repair Drugs Market Challenges
Table 162. DNA Repair Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DNA Repair Drugs
Figure 2. Global DNA Repair Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global DNA Repair Drugs Market Share by Type in 2024 & 2034
Figure 4. PARP Inhibitors Product Picture
Figure 5. Other Product Picture
Figure 6. Global DNA Repair Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global DNA Repair Drugs Market Share by Application in 2024 & 2034
Figure 8. Oncological
Figure 9. Stroke
Figure 10. Global DNA Repair Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global DNA Repair Drugs Market Size (2018-2034) & (US$ Million)
Figure 12. Global DNA Repair Drugs Sales (2018-2034) & (K Units)
Figure 13. Global DNA Repair Drugs Average Price (USD/Unit) & (2018-2034)
Figure 14. DNA Repair Drugs Report Years Considered
Figure 15. DNA Repair Drugs Sales Share by Manufacturers in 2024
Figure 16. Global DNA Repair Drugs Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest DNA Repair Drugs Players: Market Share by Revenue in 2024
Figure 18. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global DNA Repair Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America DNA Repair Drugs Sales Market Share by Country (2018-2034)
Figure 21. North America DNA Repair Drugs Revenue Market Share by Country (2018-2034)
Figure 22. U.S. DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe DNA Repair Drugs Sales Market Share by Country (2018-2034)
Figure 25. Europe DNA Repair Drugs Revenue Market Share by Country (2018-2034)
Figure 26. Germany DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2018-2034)
Figure 33. China DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America DNA Repair Drugs Sales Market Share by Country (2018-2034)
Figure 44. Latin America DNA Repair Drugs Revenue Market Share by Country (2018-2034)
Figure 45. Mexico DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa DNA Repair Drugs Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa DNA Repair Drugs Revenue Market Share by Country (2018-2034)
Figure 50. Turkey DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. U.A.E DNA Repair Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of DNA Repair Drugs by Type (2018-2034)
Figure 54. Global Revenue Market Share of DNA Repair Drugs by Type (2018-2034)
Figure 55. Global DNA Repair Drugs Price (USD/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of DNA Repair Drugs by Application (2018-2034)
Figure 57. Global Revenue Market Share of DNA Repair Drugs by Application (2018-2034)
Figure 58. Global DNA Repair Drugs Price (USD/Unit) by Application (2018-2034)
Figure 59. DNA Repair Drugs Value Chain
Figure 60. DNA Repair Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed